Nationwide Fund Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-16,365
| Closed | -$297K | – | 498 |
|
|
2017
Q3 | $297K | Hold |
16,365
| – | – | ﹤0.01% | 2442 |
|
|
2017
Q2 | $254K | Buy |
16,365
+4,622
| +39% | +$71.7K | ﹤0.01% | 2527 |
|
|
2017
Q1 | $203K | Sell |
11,743
-1,182
| -9% | -$20.4K | ﹤0.01% | 2578 |
|
|
2016
Q4 | $142K | Hold |
12,925
| – | – | ﹤0.01% | 2753 |
|
|
2016
Q3 | $203K | Hold |
12,925
| – | – | ﹤0.01% | 2610 |
|
|
2016
Q2 | $132K | Buy |
12,925
+7,688
| +147% | +$78.5K | ﹤0.01% | 2810 |
|
|
2016
Q1 | $68K | Buy |
5,237
+624
| +14% | +$8.1K | ﹤0.01% | 2926 |
|
|
2015
Q4 | $96K | Buy |
+4,613
| New | +$96K | ﹤0.01% | 2867 |
|